GlassScriptPhysician profile
Donna M Bohnert
NPI 1831531797
$1,554.03
in general payments reported to CMS, 2019-2025
18 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $228 · 2022: $473 · 2023: $217 · 2024: $240 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $393.23 | 2022-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $283.08 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $242.11 | 2021-2024 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $192.18 | 2021-2025 | Ozempic, Rybelsus |
| Verona Pharma, INC. | $102.88 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $48.68 | 2021-2023 | Trintellix |
| Glaxosmithkline, LLC. | $41.96 | 2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $40.63 | 2024-2025 | |
| Sanofi Pasteur INC. | $32.57 | 2021-2023 | |
| Exact Sciences Corporation | $31.63 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $30.00 | 2025 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $24.01 | 2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $17.46 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.93 | 2022 | |
| Grifols USA, LLC | $15.54 | 2023 | Prolastin-C Liquid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $15.17 | 2024 | Auvelity |
| Corium, LLC | $14.67 | 2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Bohnert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.